ABSTRACT Avian coccidiosis is caused by the intracellular protozoan Eimeria, which produces intestinal lesions leading to weight gain depression. Current control methods include vaccination and anticoccidial drugs. An alternative approach involves modulating the immune system. The objective of this study was to profile the expression of host defense peptides such as avian beta-defensins (AvBDs) and liver expressed antimicrobial peptide 2 (LEAP2), which are part of the innate immune system. The mRNA expression of AvBD family members 1, 6, 8, 10, 11, 12, and 13 and LEAP2 was examined in chickens challenged with either E. acervulina, E. maxima, or E. tenella. The duodenum, jejunum, ileum, and ceca were collected 7 d post challenge. In study 1, E. acervulina challenge resulted in down-regulation of AvBD1, AvBD6, AvBD10, AvBD11, AvBD12, and AvBD13 in the duodenum. E. maxima challenge caused down-regulation of AvBD6, AvBD10, and AvBD11 in the duodenum, down-regulation of AvBD10 in the jejunum, but upregulation of AvBD8 and AvBD13 in the ceca. E. tenella challenge showed no change in AvBD expression in any tissue. In study 2, which involved challenge with only E. maxima, there was down-regulation of AvBD1 in the ileum, AvBD11 in the jejunum and ileum, and LEAP2 in all 3 segments of the small intestine. The expression of LEAP2 was further examined by in situ hybridization in the jejunum of chickens from study 2. LEAP2 mRNA was expressed similarly in the enterocytes lining the villi, but not in the crypts of control and Eimeria challenged chickens. The lengths of the villi in the Eimeria challenged chickens were less than those in the control chickens, which may in part account for the observed down-regulation of LEAP2 mRNA quantified by PCR. Overall, the AvBD response to Eimeria challenge was not consistent; whereas LEAP2 was consistently down-regulated, which suggests that LEAP2 plays an important role in modulating an Eimeria infection.
INTRODUCTION
Coccidiosis is a common disease of poultry caused by the intestinal protozoan Eimeria (Conway and McKenzie, 2007) . Infected birds usually show reduced feed efficiency and weight gain depression due to lesions in the intestinal mucosa (Kipper et al., 2013) . Damage to the intestinal barrier also increases the mortality of the birds. Eimeria infection is responsible for losses of $3 billion annually in the poultry industry (Dalloul et al., 2007) . The 3 species of Eimeria that mainly impact the poultry industry in the United States are E. acervulina, E. maxima, and E. tenella. These Eimeria species cause tissue-specific lesions, e.g., E. acervulina mainly affects the duodenum, E. maxima the jejunum, and E. tenella the ceca (Lillehoj and Trout, 1996) .
Infection with Eimeria promotes both antibody and cell-mediated immune responses (reviewed in Chapman, 2014) . Although antibodies can be abundantly produced locally, they cannot access and act on these intracellular pathogens (Lillehoj et al., 2004) . Therefore, antibody-mediated responses play a minor role in protective immunity against coccidiosis. Cell-mediated immune responses are the major host immune response during Eimeria infection, and they also can provide protection against reinfection (Lillehoj and Trout, 1996; Lillehoj and Lillehoj, 2000; Lillehoj et al., 2004) . T-lymphocytes, natural killer cells, and macrophages are involved in the avian cellular immune response to Eimeria infection (Lillehoj and Trout, 1996; Dalloul et al., 2007) . Host defense peptides not only show direct antimicrobial activity by disrupting membrane integrity but also enhance mucosal barrier 2421 function by inducing expression of mucins and tight junction proteins (Robinson et al., 2015) .
The current prevention and treatment of coccidiosis is through vaccination, anticoccidial drugs, prebiotics, probiotics, and natural compounds (Quiroz-Castaneda and Dantan-Gonzalez, 2015) . Live, wild-type coccidial vaccines can induce a strong immune response in chickens, which results in reduced feed efficiency and body weight gain. One alternative is to use precocious strains, which are defined as completing the lifecycle from sporozoite to oocyst 30 h faster than parent strains. Precocious strains show attenuated virulence but can still induce immunity. One drawback to the use of precocious strains is the additional labor and time required for numerous rounds of selection through naïve birds (Sharman et al., 2010; Chapman, 2014; Fetterer et al., 2014 ). There are 2 major types of anticoccidial drugs: coccidiostats and coccidiocidals. Coccidiostats act by inhibiting the development of Eimeria, while coccidiocidals destroy the structural integrity of Eimeria. Although these are effective, the development of drug resistance and consumer concerns about chemical residues in poultry products have caused a decrease in the use of anticoccidial drugs (Quiroz-Castaneda and Dantan-Gonzalez, 2015) . The use of natural alternatives such as fats, antioxidants, essential oils, herbal extracts, prebiotics, and probiotics have shown some promise in ameliorating the negative effects of coccidiosis (Bozkurt et al., 2014; QuirozCastaneda and Dantan-Gonzalez, 2015) . The cost of production, however, of these natural alternatives is currently high, but the cost can be offset by increased performance and use of a more environmental and consumer friendly product.
An alternative approach to disease control involves enhancement of the immune system. Innate immunity is the first line of host defense against infections in vertebrate animals (Dziarski, 2013) . Components of the innate immune system include: immune cells, host defense peptides (HDP), enzymes, and pro-inflammatory factors (Dziarski, 2013) . Host defense peptides have antimicrobial and immunomodulatory properties and show broad-spectrum activity against a range of bacteria, fungi, and enveloped viruses (Robinson et al., 2015) . Because HDP attach to and insert into membranes of microbes, there is a low risk of triggering resistance (Brogden, 2005; Melo et al., 2009) . Thus HDP are attractive candidates for use in antimicrobial therapies.
In avians, 14 avian beta-defensins (AvBD), 4 cathelicidins (CATH), and liver expressed antimicrobial peptide-2 (LEAP2) have been identified as HDP (Cuperus et al., 2013; Zhang and Sunkara, 2014) . In vitro studies showed some of these HDP have a direct negative effect on bacteria such as Campylobacter and Salmonella (Milona et al., 2007; Townes et al., 2009; van Dijk et al., 2012) . Hong et al. (2012) examined the expression of AvBD in the jejunum of Cobb and Ross broilers following an E. maxima plus Clostridium perfringens challenge to induce necrotic enteritis. In uninfected chickens, abundance of AvBD8, AvBD10, and AvBD13 mRNA was high; AvBD1, AvBD6, AvBD9, AvBD11, and AvBD12 mRNA was moderate; and AvBD3 and AvBD4 mRNA was very low. Infected Cobb and Ross chickens showed different patterns of up-regulation and down-regulation of AvBD. The expression of AvBD during an Eimeria challenge has not been reported. Thus the objective of the current study was to compare the expression profiles of AvBD in the duodenum, jejunum, ileum, and ceca of chickens following challenge with E. acervulina, E. maxima, and E. tenella. Oocysts were maintained and isolated as previously described (Fetterer and Barfield, 2003) . Broiler chickens were housed at the USDA-ARS facility (Beltsville, MD) from hatch and maintained coccidia-free in suspended wire cages. Chickens were given water and a standard starter-type corn-soybean meal, ad libitum. At 21 d of age, chicks were inoculated with Eimeria via gavage. The tissue samples were the same as those from the study reported by Su et al. (2015) . In the first experiment, chickens were inoculated with E. acervulina (200,000 oocysts/chicken, n = 6) or E. maxima (10,000 oocysts/chicken, n = 6). Control 1 (n = 6) received no Eimeria oocysts. In the second experiment, chickens were inoculated with E. tenella (150,000 oocysts/chicken, n = 6). Control 2 (n = 6) received no Eimeria oocysts. Body weights of chickens were obtained on d of challenge (d 21) and 7 d post challenge.
MATERIALS AND METHODS

Birds and Eimeria challenge
Study 2 In a separate study, Ross Heritage broiler males (Longenecker's Hatchery, Elizabethtown, PA) were challenged with only E. maxima. Housing and challenge were as described for study 1. At 21 d of age, chicks (n = 12) were inoculated via gavage with a lower dose of E. maxima (USDA APU1 isolate, 1,000 oocysts/chicken). Control (n = 12) received no Eimeria. Body weights of chickens were obtained on d of challenge (d 21) and 7 d post challenge. Six control and 6 challenged chickens were randomly chosen for gene expression analysis.
All studies were carried out under protocols approved by the Beltsville Research Center Animal Care and Use Committee and conducted at the Animal Parasitic Disease Laboratory (USDA Agricultural Research Service, Beltsville, MD). Chickens were euthanized by cervical dislocation and intestinal segments were collected on d 28 (controls and 7 d post challenge). For both studies, each of the animals showed symptoms of Eimeria infection including intestinal lesions, loosening of the feces, and petechiae. Lesions were noted but not scored. Weight gain depression was used as an objective measure to assess the extent of Eimeria infection. Duodenum, jejunum, ileum, and ceca were collected for study 1 and only duodenum, jejunum, and ileum were collected for study 2. The contents of the intestine were removed and the tissue segments were immediately stored individually in RNAlater (Invitrogen, Grand Island, NY).
RNA Extraction and Quantitative Real-time PCR
The tissue samples were removed from RNAlater (Thermo Fisher Scientific, Pittsburgh, PA) and minced. For all samples, a 20 to 30 mg sample of tissue was homogenized in TriReagent (Molecular Research Center Inc., Cincinnati, OH) and total RNA was extracted following the manufacturer's instructions of Direct-zol RNA MiniPrep Kit (Zymo Research, Irvine, CA). RNA quantity and purity were determined using a Nanodrop 1000 spectrophotometer (Thermo Fisher Scientific) and RNA quality was assessed by agarose-formaldehyde gel electrophoresis. The cDNA was synthesized from total RNA (500 ng) using the high-capacity cDNA reverse transcription kit (Thermo Fisher Scientific) and then diluted 1:30 for real-time PCR analysis. The 7 AvBD (AvBD1, AvBD6, AvBD8, AvBD10, AvBD11, AvBD12, and AvBD13) that showed the greatest expression in the intestine (Hong et al., 2012) were analyzed by quantitative real-time PCR. β-actin was chosen as the reference gene, because the Ct values for β-actin were the same for control and infected samples. In study 1, expression of 7 AvBD was examined, while for study 2, expression of 7 AvBD and LEAP2 was examined. The forward and reverse primers for the 7 AvBD, LEAP2, and β-actin are shown in Table 1 . qPCR was performed on an Applied Biosystems 7500 system with Fast SYBR green (Thermo Fisher Scientific, Waltham, MA) using the following conditions for all genes: 95
• C for 20 s followed by 40 cycles of 95
• C for 3 s and 60
• C for 30 seconds. Samples were run in duplicate and relative gene expression data were analyzed using the 2 −ΔΔCt method (Livak and Schmittgen, 2001) , as described in Su et al. (2015) . The mean ΔCt of the control samples was used to calculate the ΔΔCt value, which was performed separately for each intestinal segment. Eimeria treatment and each gene are a group.
In situ Hybridization and Morphology Analysis
In situ hybridization (ISH) was performed using the RNAscope method (Advanced Cell Diagnostics, ACD, Newark, CA) as described by Wang et al. (2012) . Three intestinal samples from both control and E. maxima challenged jejunal tissue were fixed in phosphate buffered 4% paraformaldehyde and embedded in paraffin. Sections (5 to 6 μm) were cut with a microtome and the expression of LEAP2 mRNA was assayed by ISH using a set of custom synthesized probes for chicken LEAP2 (ACD). The tissue sections were processed according to the manufacturer's directions using the HybEZ oven and the RNAscope 2.5 HD detection kitBrown (ACD). Following RNA scope processing, the slides were stained with a 50% Gill #2 hematoxylin solution (Sigma Aldrich, St Louis, MO), rinsed in water, and then placed in 0.02% ammonia water. After air drying, a drop of Clear Mount solution (American Master Tech Scientific, Inc, Lodi, CA) was added and a coverslip was placed on top. Images were captured at various magnifications with a Nikon Eclipse 80i microscope and DS-Ri1 digital camera. Villus length was measured from the top of the intestinal crypt to the tip of the villus for intact villi (n > 30) from different samples using Infinity Analyze imaging software (Lumenera Co., Ottawa, Ontario).
Statistical Analysis
PCR data were analyzed by ANOVA using JMP R Statistical Discovery Software from SAS (SAS Institute, Cary, NC). For study 1, control 1 and E. acervulinaand E. maxima-challenged chickens were analyzed separately from control 2 and E. tenella-challenged chickens. For gene expression of each Eimeria challenge, the model included the main effects of treatment, sorted by genes. Significance level was set at P < 0.05 when compared with the control. Villus length was analyzed by t-test.
RESULTS
Eimeria challenge caused the expected weight gain depression from d of challenge (d 21) to d of sample collection (d 28). In study 1, E. acervulina, E. maxima, Figure 1 . Expression of avian beta-defensins (AvBD) in the duodenum of E. acervulina, E. maxima, and E. tenella-challenged broilers (study 1). Doses were 200,000, 10,000, and 150,000 oocysts/chicken for E. acervulina, E. maxima, and E. tenella, respectively. Controls (nonchallenged) are equal to a fold change of one for each AvBD.
* indicates statistical significance from control at P < 0.05. Figure 2 . Expression of avian beta-defensins (AvBD) in the jejunum of E. acervulina, E. maxima, and E. tenella challenged broilers (study 1). Doses were 200,000, 10,000, and 150,000 oocysts/chicken for E. acervulina, E. maxima, and E. tenella, respectively. Controls (nonchallenged) are equal to a fold change of one for each AvBD.
* indicates statistical significance from control at P < 0.05. and E. tenella challenge resulted in a 42, 30, and 24% weight gain depression (Su et al., 2015) . In study 2, the control chickens (n = 6) weighed on average 817±24 g at d 21 (challenge d) and 1,311±47 g at d 28 (sampling d), for an average weight gain of 494±28 g/chicken. In contrast, the E. maxima challenged chickens (n = 6) weighed on average 725±58 g at d 21 and 1,144±79 g at d 28 for an average weight gain of 418±24 g, which equaled a 15% weight gain depression (P < 0.05).
In study 1, the expression of 7 AvBD was profiled in the small intestine and ceca of broilers challenged with E. acervulina, E. maxima, or E. tenella. In the duodenum (Figure 1 ), E. acervulina challenge resulted in the down-regulation of AvBD1, AvBD6, AvBD10, AvBD11, AvBD12, and AvBD13 to 15 to 42% of control. E. maxima challenge caused down-regulation of AvBD6, AvBD10, and AvBD11 to 37 to 51% of control, while E. tenella challenge had no effect on expression of any AvBD. In the jejunum (Figure 2 ), E. maxima caused down-regulation of AvBD10 to 34% of control. Both E. acervulina and E. tenella showed no changes in expression of AvBDs. In the ileum (Figure 3) , none Figure 3 . Expression of avian beta-defensins (AvBD) in the ileum of E. acervulina, E. maxima, and E. tenella challenged broilers (study 1). Doses were 200,000, 10,000, and 150,000 oocysts/chicken for E. acervulina, E. maxima, and E. tenella, respectively. Controls (nonchallenged) are equal to a fold change of one for each AvBD. Figure 4 . Expression of avian beta-defensins (AvBD) in the ceca of E. acervulina, E. maxima, and E. tenella challenged broilers (study 1). Doses were 200,000, 10,000, and 150,000 oocysts/chicken for E. acervulina, E. maxima, and E. tenella, respectively. Controls (nonchallenged) are equal to a fold change of one for each AvBD.
* indicates statistical significance from control at P < 0.05. of the 3 Eimeria species caused changes in AvBD expression. In the ceca (Figure 4 ), E. maxima challenge resulted in an increase of 242 and 201% above control for AvBD8 and AvBD13, respectively. There were no changes in gene expression for E. acervulina or E. tenella challenge in the ceca.
In study 2, the expression of 7 AvBD plus LEAP2 was examined in the duodenum, jejunum, and ileum of E. maxima challenged chickens ( Figure 5 ). In the duodenum, there was no change in the expression of the AvBD. In the jejunum, there was down-regulation of AvBD11 to 40% of control; and in the ileum there was down-regulation of AvBD1 and AvBD11 to 69 and 64% of control, respectively. LEAP2 was down-regulated to 46, 48, and 45% of control in the duodenum, jejunum, and ileum, respectively.
Expression of LEAP2 mRNA was evaluated by ISH in the jejunum of control and E. maxima challenged chickens from study 2 (Figure 6 ). LEAP2 mRNA (brown staining) was detected in the epithelial cells that line the villi, but not in the crypts of the jejunum of both the control and E. maxima challenged chickens. At the tips of the villi in the control tissues there was little to no staining for LEAP2 mRNA in the epithelial cells, Figure 5 . Expression of avian beta defensins and LEAP2 in the duodenum (DU), jejunum (JE), and ileum (IL) of E. maxima (1,000 oocysts/chicken) challenged broilers (study 2). Controls (nonchallenged) are equal to a fold change of one for each AvBD.
* indicates statistical significance from control at P < 0.05.
indicating that these cells were no longer expressing LEAP2 mRNA. The lengths of the villi also were examined in the histological sections. The villus length in the control chickens (1,210 ± 94 μm) was greater (P < 0.001) than that in the E. maxima challenged chickens (788 ± 141 μm).
DISCUSSION
Eimeria is a protozoa that invades intestinal epithelial cells and induces an immune response. The antimicrobial peptide LEAP2 was down-regulated in the small intestine following challenge with E. acervulina, E. maxima, E. tenella, and E. praecox (Casterlow et al., 2011; Sumners et al., 2011; Paris and Wong, 2013; Su et al., 2014 Su et al., , 2015 Yin et al., 2015) . Using a necrotic enteritis model induced by initial challenge with E. maxima followed by challenge with Clostridium perfringens, Hong et al. (2012) reported the expression of HDP in the jejunum of both Cobb and Ross broilers. In Cobb broilers showing necrotic enteritis, AvBD3, AvBD4, and AvBD12 were down-regulated, while AvBD8, AvBD11, and AvBD13 were up-regulated. Ross broilers showed a different pattern with only AvBD12 down-regulated and AvBD1, AvBD6, AvBD8, and AvBD10 up-regulated. Because expression of AvBD in birds infected with only E. maxima was not reported in Hong et al (2012) , changes in gene expression cannot be definitively attributed to the effect of Eimeria, Clostridium, or both. Since we observed only a few changes in AvBD expression following Eimeria challenge, most of the changes in AvBD expression reported by Hong et al. (2012) during necrotic enteritis are likely due to the secondary Clostridium infection.
In our studies, we compared the expression of AvBD in chickens infected with 3 different Eimeria species. Our results in study 1 showed that AvBD were downregulated in E. acervulina and E. maxima infected chickens in different intestinal segments, similar to the down-regulation reported for LEAP2 (Su et al., 2015) . There was common down-regulation of LEAP2, AvBD6, AvBD10, and AvBD11 in the duodenum of E. acervulina and E. maxima infected chickens. E. acervulina also showed down-regulation of AvBD1, AvBD12, and AvBD13 in the duodenum and no effect in the jejunum, ileum, or ceca. This is consistent with E. acervulina causing lesions in the duodenum. E. maxima also caused down-regulation of AvBD10 and LEAP2 (Su et al., 2015) in the jejunum, which is the site for E. maxima lesions. Interestingly in the ceca of E. maxima challenged broilers, there was up-regulation of AvBD8 and AvBD13. E. tenella challenged broilers had no effect on AvBD expression in any intestinal segment and caused down-regulation of LEAP2 only in the ceca (Su et al., 2015) .
In study 2, E. maxima challenge resulted in a different pattern of AvBD expression. There was no change in gene expression in the duodenum and only downregulation of AvBD1 in the ileum and AvBD11 in the jejunum and ileum. In contrast, in study 1 AvBD1 showed no changes, and AvBD11 was down-regulated only in the duodenum. Consistent with previous Figure 6 . In situ hybridization analysis of LEAP2 mRNA. Formalin fixed paraffin embedded jejunal samples from control (A) and E. maxima challenged (B) chickens from study 2 were assayed by in situ hybridization using the RNA scope 2.5 HD kit (Brown). Brown staining revealed the presence of LEAP2 mRNA. The tissues were counterstained with 50% hematoxylin. Images were captured using 100x magnification. studies, LEAP2 was down-regulated in all 3 segments of the small intestine (Su et al., 2014 (Su et al., , 2015 . In this study, ceca were not collected. The difference in AvBD results may be partly due to the challenge dose. In study 1, 10,000 E. maxima oocysts were gavaged, whereas in study 2, only 1,000 E. maxima oocysts were gavaged. The different E. maxima dosages were consistent with the weight gain depression observed. Study 1 resulted in 30% weight gain depression and study 2 resulted in 15% weight gain depression. These results show that the AvBD response to Eimeria challenge was not always consistent, in contrast to the consistent downregulation of LEAP2.
Because HDP are part of the innate immune system, they would be expected to serve as the first line of defense during a pathogen challenge. Sumners et al. (2011) examined the temporal changes in expression of LEAP 2 and cathelicidin 3 in the duodenum and jejunum of broilers challenged with 50,000 or 500,000 E. praecox oocysts at daily intervals from d 1 to d 7 post challenge. They found that the lower dose of E. praecox caused down-regulation of LEAP2 in the duodenum at d 3 and the duodenum and jejunum at d 4 post challenge. At the higher Eimeria dose, LEAP2 was down-regulated in the duodenum at d 3, d 4, and d 5. Cathelicidin 3 was down-regulated in the jejunum at only d 3 following challenge with the low dose of Eimeria. Thus the downregulation of LEAP2 and cathelicidin 3 does not occur immediately after challenge, but requires 3 d post challenge to develop. In this study, expression of the AvBD was not examined. It would be interesting to analyze the expression of AvBD at different d after challenge.
In situ hybridization was used to examine LEAP2 mRNA expression because it has the advantage of being able to identify individual cells expressing LEAP2 mRNA, which cannot be revealed by qPCR. Our results show that LEAP2 mRNA was expressed in the epithelial cells lining the villi in both the control and E. maxima challenged chickens. In addition, LEAP2 mRNA was not localized to cells in the crypt, which is the site for intestinal stem cells in mammals (Carulli et al., 2014) . This result is consistent with the results of Howard et al. (2010) , who showed by immunohistochemical analysis that LEAP2 protein was localized to epithelial cells lining the colonic crypts and the proximal and distal tubules of the kidney.
Morphological analysis of the villi of control and E. maxima challenged chickens in study 2 revealed that although the jejunal villi in E. maxima challenged chickens were shorter than villi in control chickens, the epithelial cells of both villi were functional as shown by similar expression of LEAP2 mRNA by ISH in the epithelial cells. Furthermore, the samples analyzed for AvBD mRNA expression in study 1 were the same samples previously analyzed for expression of amino acid, peptide, and monosaccharide transporters (Su et al., 2015) . This study showed that some transporters had unchanged expression following Eimeria challenge, while others showed increased or decreased expression.
These results demonstrate that the intestinal epithelial cells in both of our studies were intact and functional following Eimeria challenge. Analysis of the villi from study 2 showed that the villi from the E. maxima challenged chickens were on average 65% of the length of control chickens. Because there appeared to be no qualitative difference in intensity of ISH staining for LEAP2 in the jejunum between control and E. maxima challenged chickens, the down-regulation of LEAP2 to 48% of control as quantified by qPCR may in part be attributable to the shortening of the villi.
In summary, at 7 d post challenge, LEAP2 was consistently down-regulated following Eimeria challenge, whereas the AvBD response was variable and may be dose dependent. LEAP2 mRNA was expressed similarly in the epithelial cells lining the villi of control and E. maxima challenged chickens.
